Structure and Chemical Inhibition of the Ret Tyrosine Kinase Domain.
Knowles, P.P., Murray-Rust, J., Kjaer, S., Scott, R.P., Hanrahan, S., Santoro, M., Ibanez, C.F., McDonald, N.Q.(2006) J Biol Chem 281: 33577-33587
- PubMed: 16928683 
- DOI: 10.1074/jbc.M605604200
- Primary Citation of Related Structures:  
2IVV, 2IVU, 2IVT, 2IVS - PubMed Abstract: 
The RET proto-oncogene encodes a receptor tyrosine kinase for the glial cell line-derived neurotrophic factor family of ligands. Loss-of-function mutations in RET are implicated in Hirschsprung disease, whereas activating mutations in RET are found in human cancers, including familial medullar thyroid carcinoma and multiple endocrine neoplasias 2A and 2B ...